CIK 0002007919 · <br>Emerging growth company
Inhibrx Biosciences, Inc.
Sign in to watch- Ticker
- INBX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 990613523
- Phone
- (858) 795-4220
- Business address
- 11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, CA, 92037
- 8-K Event Regulation FD disclosure · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure · Other events
- 4 Derivatives Options or other derivatives
Page 2 of 8 · 158 filings